Yasser Falah

Neurologist - MS & Neuroinflammation @KingsCollegeNHS, Liberal, Arsenal supporter, Personal views only

[Yasser Falah @dr_ymf]

The wait is over 🏆

[Yasser Falah @dr_ymf]

@DrRhiRafty Posters also mentioned cladribine including post NAT 👍

[Dr David Nicholl @djnicholl]

Seen 'Gaza: Doctors Under Attack'?

Utterly horrific documentary which demands investigation into the deliberate targeting, torture & alleged murder of healthcare workers in #Gaza

https://t.co/HfGDplYm8L

[Dr. Brandon Beaber @Brandon_Beaber]

Multiple Sclerosis Treated Early and Aggressively. Results of an observational study: Do people still develop progressive MS? https://t.co/c1UhjGesPX

[Varun Mehra @docbmt]

Hot off the press!

Our UK wide 20years experience of Autologous #HSCT in #MultipleSclerosis reaffirming its significant benefits even with advanced disability
@BSBMT @BritSocHaem @BrJHaem @TheEBMT @KingsCollegeNHS @mssocietyuk @MSTrust
Key findings👇🏻
https://t.co/ax20f9L0iw

[Yasser Falah @dr_ymf]

@Brandon_Beaber While we’re fighting in the UK to make Rituximab as 1st line option!!!!!

[Chris Wincup @chriswincup]

🚨 Reminder - there is still time to register for our FREE Autoimmune CAR T Symposium 🚨

🗓️ Wed 20th November
⏰ 12.00 registration / lunch, 12.30 start. Concluding at 5.15pm and will be followed by drinks and networking opportunities
🔗 https://t.co/TmgQbbfoIr

[Pedro Machado @pedrommcmachado]

CAR T in Autoimmune Disease Conference | London, Friday, 27Sep24 | Last places available | Book now | https://t.co/aCNFHKP5uu | @UCL_QS_CNMD @RheumTrialsUCL @UCLBrainScience @uclmedsci @uclh @RheumatologyUK

[The Neurology Hub @TheNeurologyHub]

Autologous hematopoietic #stem_cell transplantation demonstrated superiority to #Lemtrada (#alemtuzumab) in improving clinical and radiological outcomes for people with relapsing-remitting #Multiple_Sclerosis, according to real-world data presented at #ECTRIMS2024.

https://t.co/7FjApNUoFw
@ECTRIMS @mscare @mssociety #AHSCT #RRMS #MS

[Yasser Falah @dr_ymf]

One of the best @ECTRIMS annual meetings, thanks for the organisers and looking forward to Barcelona 2025 🌟

[Rhian Raftopoulos @DrRhiRafty]

Tolebrutinib does have significant effect and confirmed disability progression in both secondary progressive and relapsing remitting MS with 30% reduction in CDP at 6 months. Appear independent of relapses. Liver impairment remains concern, occurs in first 90 days

[Rhian Raftopoulos @DrRhiRafty]

Reassuring data from SOPRANINO study in mothers receiving Ocrelizumab while breastfeeding there was negligible transfer into breast milk, undetectable levels in baby’s serum and B cells within normal limits in baby

[Yasser Falah @dr_ymf]

Day 1 #ECTRIMS24 🌟

[Yasser Falah @dr_ymf]

@AlAlBayati1 @Matt_StarrMD @PittStroke @PittNeurology @PittNeurosurg @ChildrensPgh @UPMCPhysicianEd 👏👏👏

[Yasser Falah @dr_ymf]

@drruthdobson @ben_m_jacobs Well done Ben 👏

[Yasser Falah @dr_ymf]

@GavinGiovannoni There is good data which suggest that scanning the spine annually in people who have no new symptoms is extremely unlikely to show a new change. Having said that, scanning the cord every 2-3 years is reasonable, logical, and keeps our Neuroradiologists sanity!

[Yasser Falah @dr_ymf]

The on call week feels good if you have almost all main neurological conditions represented - both central and peripheral nervous system 😊💉💊🦠🧠👁️

[Yasser Falah @dr_ymf]

@GavinGiovannoni RIP Matt, huge loss 😔

[Yasser Falah @dr_ymf]

@DrRhiRafty The never ending nightmare 😔